ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01578954
Recruitment Status : Active, not recruiting
First Posted : April 17, 2012
Last Update Posted : March 22, 2018
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 3, 2016
  Estimated Study Completion Date : March 2022